If subsidiary vascular thrombosis and other vascular complications can be minimized, VEGF inhibitors, if not of the conventional kind, can still be favorable in depleting the prognosis of tumor cells through blocking angiogenesis [30]. This evidence concerns the gene VEGFA and neoplasm.